by Rady Ananda After a 2012 study linking cancer with Monsanto’s genetically modified corn, the scientific journal that published the study is now retracting it, after hiring a former Monsanto employee to fill a new editorial position reviewing biotechnology papers. In September 2012, the scientific journal, Food and Chemical Toxicology(FCT), published the study of Gilles-Eric Séralini, et al. which reviewed the toxicological effects of Monsanto’s NK603, and its requisite Round-Up pesticide. They found “severe toxic effects (including liver congestions, necrosis and kidney nephropathies), increased tumor rates and higher mortality in rats fed Monsanto’s genetically modified NK603 maize and/or the associated herbicide Roundup.” In February of 2013, the FCT hired Monsanto’s former employee, Richard E. Goodman, for a new position reviewing biotechnology papers. On November 19, the FCT reported its decision to retract the published paper stating the study’s results were inconclusive because there weren’t enough rats used in the study, and the strain of rat used was not acceptable. Writing for CRIIGEN, the independent lab with which Seralini is affiliated, Frédérique Baudouin noted that a short Monsanto study, which was published in the same journal to prove the safety of its product, “was conducted with the same strain and number of rats.” Séralini has promised to sue.
Monsanto behind Journal’s retraction of GMO rat-cancer link